Harmony Garges
Director/Board Member chez MEDEXUS PHARMACEUTICALS INC.
Fortune : 16 163 $ au 31/03/2024
Profil
Harmony P.
Garges has worked as a Director at Medexus Pharmaceuticals, Inc. since 2023 and as the Chief Medical Officer at ViiV Healthcare Ltd.
since 2019.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
29/09/2023 | 13 259 ( 0,05% ) | 16 163 $ | 31/03/2024 |
Postes actifs de Harmony Garges
Sociétés | Poste | Début |
---|---|---|
MEDEXUS PHARMACEUTICALS INC. | Director/Board Member | 06/02/2023 |
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Chief Tech/Sci/R&D Officer | 01/08/2019 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
MEDEXUS PHARMACEUTICALS INC. | Health Technology |
Entreprise privées | 1 |
---|---|
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Health Technology |